GSK Loses Bid To Bar Testimony On Avandia Risks
GlaxoSmithKline PLC has lost its bid to block three doctors from testifying about the alleged health risks of Avandia in a multidistrict litigation alleging the company concealed the diabetes medication's potential...To view the full article, register now.
Already a subscriber? Click here to view full article